South Africa Cancer Monoclonal Antibodies Market Size & Outlook
Related Markets
South Africa cancer monoclonal antibodies market highlights
- The South Africa cancer monoclonal antibodies market generated a revenue of USD 768.3 million in 2023 and is expected to reach USD 2,414.1 million by 2030.
- The South Africa market is expected to grow at a CAGR of 17.7% from 2024 to 2030.
- In terms of segment, humanized was the largest revenue generating type in 2023.
- Human is the most lucrative type segment registering the fastest growth during the forecast period.
Cancer monoclonal antibodies market data book summary
| Market revenue in 2023 | USD 768.3 million |
| Market revenue in 2030 | USD 2,414.1 million |
| Growth rate | 17.7% (CAGR from 2024 to 2030) |
| Largest segment | Humanized |
| Fastest growing segment | Human |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Humanized, Human, Chimeric, Murine |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.9% of the global cancer monoclonal antibodies market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa cancer monoclonal antibodies market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 1,151.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Monoclonal Antibodies Market Scope
Cancer Monoclonal Antibodies Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| GlaxoSmithKline Consumer Healthcare (GSK CH India) | View profile | 1001-5000 | Gurgaon, Haryana, India, Asia | https://india-consumer.gsk.com/ |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
South Africa cancer monoclonal antibodies market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cancer monoclonal antibodies market will help companies and investors design strategic landscapes.
Humanized was the largest segment with a revenue share of 47.52% in 2023. Horizon Databook has segmented the South Africa cancer monoclonal antibodies market based on humanized, human, chimeric, murine covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to South Africa cancer monoclonal antibodies market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Africa cancer monoclonal antibodies market databook
-
Our clientele includes a mix of cancer monoclonal antibodies market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa cancer monoclonal antibodies market , including forecasts for subscribers. This country databook contains high-level insights into South Africa cancer monoclonal antibodies market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Africa cancer monoclonal antibodies market size, by type, 2018-2030 (US$M)
South Africa Cancer Monoclonal Antibodies Market Outlook Share, 2023 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
